CLASS 46
Now in its twelfth year, Class 46 is dedicated to European trade mark law and practice. This weblog is written by a team of enthusiasts who want to spread the word and share their thoughts with others.
Want to receive Class 46 by email?
Click here subscribe for free.
Click here subscribe for free.
Who we all are...
WEDNESDAY, 2 JUNE 2010
Poland: reading comprehension
In the Regulation of the Minster of Health of 26 April 2010 on the leaflet readability test, the Polish Minister of Health provided the principles of examination under which the content of the information attached to the pharmaceutical products is understandable.
The readability test of a pharmaceutical product’s leaflet is carried out by the responsible entity (an entrepreneur who applies for or has received the marketing authorization for a medicinal product), or any other person on its behalf, to ensure that a consumer understands the relevant information contained in this leaflet and will be able to correctly apply the medicinal product. The readability test should be conducted with the following minimum requirements:
- a leaflet should be in the version that will be attached to the packaging of a pharmaceutical product, or its color layout design;
- test participants are those who may use the medicinal product, including those who have difficulty understanding written information.
The test is carried out with ten participants. A positive test result means that for each question, 90% of study participants may find the information on a given leaflet, of which 90% may show their understanding and give the correct answer and to proceed with the medicinal product. Posted by: Tomasz Rychlicki @ 10.35
Tags: pharmaceutical trade marks, design, leaflet,,
Sharing on Social Media? Use the link below...
Perm-A-Link: https://www.marques.org/blogs/class46?XID=BHA1854
Poland: reading comprehension
The readability test of a pharmaceutical product’s leaflet is carried out by the responsible entity (an entrepreneur who applies for or has received the marketing authorization for a medicinal product), or any other person on its behalf, to ensure that a consumer understands the relevant information contained in this leaflet and will be able to correctly apply the medicinal product. The readability test should be conducted with the following minimum requirements:
- a leaflet should be in the version that will be attached to the packaging of a pharmaceutical product, or its color layout design;
- test participants are those who may use the medicinal product, including those who have difficulty understanding written information.
The test is carried out with ten participants. A positive test result means that for each question, 90% of study participants may find the information on a given leaflet, of which 90% may show their understanding and give the correct answer and to proceed with the medicinal product. Posted by: Tomasz Rychlicki @ 10.35
Tags: pharmaceutical trade marks, design, leaflet,,
Sharing on Social Media? Use the link below...Perm-A-Link: https://www.marques.org/blogs/class46?XID=BHA1854
Reader Comments: 0
Post a Comment
MARQUES does not guarantee the accuracy of the information in this blog. The views are those of the individual contributors and do not necessarily reflect those of MARQUES. Seek professional advice before action on any information included here.
The Class 46 Archive
